# 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

> **NCT04831307** · NA · UNKNOWN · sponsor: **British Columbia Cancer Agency** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer
- Prostatic Neoplasm
- Prostatic Disease
- Urogenital Neoplasms
- Disease Attributes
- Neoplasms

## Interventions

- **OTHER:** [68Ga]Ga-HTK03149 PET/CT

## Key facts

- **NCT ID:** NCT04831307
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-30
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831307, "68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04831307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*